Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Della Porta MG
J Clin Oncol. 34(30):3627-3637. doi: 10.1200/JCO.2016.67.3616
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F
Lancet Haematol. 2020 Aug 13;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
Bersanelli M
J Clin Oncol. 2021 Feb 4;39(11):1223-1233. doi: 10.1200/JCO.20.01659
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Rossi M
Blood. 138(21):2093-2105. doi: 10.1182/blood.2021011320
Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome.
Rigoni R
J Allergy Clin Immunol. 2020 Apr 18;146(5):1165-1179.e11. doi: 10.1016/j.jaci.2020.04.005
Cellular Senescence in Immunity against Infections.
Marrella V, Facoetti A, Cassani B
Int J Mol Sci. 2022 Oct 6;23(19)doi: 10.3390/ijms231911845
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.
Zaglia T
Proc Natl Acad Sci U S A. 2017 Oct 9;114(43):E9006-E9015. doi: 10.1073/pnas.1708772114
Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts: when CUPIDO hits the nano-revolution in cardiology.
Catalucci D
Eur Heart J. 42(34):3217-3220. doi: 10.1093/eurheartj/ehab266
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
Roncarati R
J Am Coll Cardiol. 2013 Oct 23;63(9):920-7. doi: 10.1016/j.jacc.2013.09.041
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.
Chen J
Nat Genet. 2018 Jan 15;50(2):219-228. doi: 10.1038/s41588-017-0026-3